slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 100,021-100,050
Pages 3,953
Rows per page 30
Component
100,021-100,050 of 118,578
01
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup1 hit
11
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
03
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
04
Uses a hub-and-spoke diagram to center the company's focus on 'Building Owners'.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
07
The slide uses a path metaphor to contrast Limbach's focus on optimization against competitors focused on new construction.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
Uses a checkmark/cross matrix to demonstrate competitive advantage.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue growth.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The slide uses a checklist-style framework to justify an M&A transaction.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Why Now1 hit
18
The slide uses a check-list format to justify the strategic rationale for an M&A deal.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Why Now1 hit
25
Includes a detailed footnote explaining the use of non-GAAP financial measures and specific restructuring costs.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
28
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
01
Lion Electric | Investor Presentation Deck | 30 slidesLion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 1 hit
05
Lion Electric | Investor Presentation Deck | 30 slidesLion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 1 hit
06
Uses a comparison table format to show status of two products.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Beat · ProductLoop · Voice Of Customer1 hit
07
The slide uses a comparison table format to show the status of four different vehicle models.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Beat · ProductLoop · Voice Of Customer1 hit
13
Lion Electric | Investor Presentation Deck | 30 slidesLion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Loop · Why Now1 hit
18
Includes detailed footnotes explaining adjustments to EBITDA.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations 1 hit
03
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
13
Includes a table of revenue growth drivers and a stacked bar chart showing revenue mix.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
16
The slide uses a combination of a dual-axis bar/line chart for leverage and a stacked bar chart for liquidity capacity.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
18
The slide includes a detailed disclaimer regarding the assumptions and non-GAAP measures used in the outlook.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
26
Includes a map of Europe with color-coded regions and location markers.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Market Size1 hit
32
The slide uses a matrix structure to compare three business segments (FinishMaster, Canadian Automotive Group, UK Aftermarket Parts) against strategic rationale and key figures.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
38
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
49
The table includes both financial figures in millions and vehicle counts in thousands.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
50
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
11
This slide serves as a validation/traction point by highlighting a partnership with a major pharmaceutical company.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
13
The slide outlines a multi-part clinical trial process (Part A, Part B, and Expansion) for NSCLC 2L patients.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
18
DCR = Disease Control Rate. Data shows high efficacy across all tested dose levels.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
23
The slide outlines a multi-stage clinical trial design (Part A/B to Part C) involving immune activation with various checkpoint inhibitors.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit